Microarray analysis of microRNA expression in renal clear cell carcinoma

European Journal of Surgical Oncology

Volumn 35, Issue 10, 2009, Pages 1119-1123

  Huang, Y ^a   Dai, Y ^b   Yang, J ^b   Chen, T ^b   Yin, Y ^a   Tang, M ^a   Hu, C ^b   Zhang, L ^b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Human; Microarray; MicroRNA; Renal cell carcinoma

Indexed keywords

MICRORNA;

ADULT; ARTICLE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GEL ELECTROPHORESIS; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; KIDNEY CARCINOMA; MALE; MICROARRAY ANALYSIS; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION;

ADULT; CARCINOMA, RENAL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 69949096535     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.04.010     Document Type: Article

References (28)

1. Available at:. In: Ries L.A.G., Harkins D., and Krapcho M. (Eds). SEER cancer statistics review, 1975-2003 (2006), National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2003/ [accessed 15.09.06]
2. Bukowski R.M. Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2. Cancer 80 (1997) 1198-1220
3. Bukowski R.M. Immunotherapy in renal cell carcinoma. Oncology (Williston Park) 13 (1999) 801-810
4. McDermott D.F., Regan M., Clark J.I., et al. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. J Clin Oncol 23 (2005) 133-141
5. Presta L.G., Chen H., O'Connor S.J., et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57 (1997) 4593-4599
6. Rini B.I., and Small E.J. Biology and clinical development of vascular endothelial growth factor targeted therapy in renal cell carcinoma. J Clin Oncol 23 (2005) 1028-1043
7. Kourembanas S., Hannan R.L., and Faller D.V. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest 86 (1990) 670-674
8. Meister G., and Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 431 (2004) 343-349
9. Abbott A.L., Alvarez-Saavedra E., Miska E.A., et al. The let-7 microRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev Cell 9 (2005) 403-414
10. Bernstein E., Kim S.Y., Carmell M.A., et al. Dicer is essential for mouse development. Nat Genet 35 (2003) 215-217
11. Chen C.Z., Li L., Lodish H.F., and Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004) 83-86
12. Jin P., Alisch R.S., and Warren S.T. RNA and microRNAs in fragile × mental retardation. Nat Cell Biol 6 (2004) 1048-1053
13. Mourelatos Z., Dostie J., Paushkin S., et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 16 (2002) 720-728
14. Gregory R.I., Yan K.P., Amuthan G., et al. The microprocessor complex mediates the genesis of microRNAs. Nature 432 (2004) 235-240
15. Poy M.N., Eliasson L., Krutzfeldt J., et al. A pancreatic iHCCt-specific microRNA regulates insulin secretion. Nature 432 (2004) 226-230
16. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
17. Johnson S.M., Grosshans H., Shingara J., et al. RAS is regulated by the let-7 microRNA family. Cell 120 (2005) 635-647
18. Calin G.A., Sevignani C., Dumitru C.D., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci 101 (2004) 2999-3004
19. Murakami Y., Yasuda T., Saigo K., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25 (2006) 2537-2545
20. Pogribny I.P., Tryndyak V.P., Boyko A., Rodriguez-Juarez R., Beland F.A., and Kovalchuk O. Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat Res 619 (2007) 30-37
21. Peng W.T., Robinson M.D., Mnaimneh S., et al. A panoramic view of yeast noncoding RNA processing. Cell 113 (2003) 919-933
22. Strumberg D. Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment. Drugs Today (Barc) 41 (2005) 773-784
23. Favaro J.P., and George D.J. Targeted therapy in renal cell carcinoma. Expert Opin Invest Drugs 14 (2005) 1251-1258
24. Eto M., and Naito S. Molecular targeting therapy for renal cell carcinoma. Int J Clin Oncol 11 (2006) 209-213
25. Larkin J.M., and Eisen T. Kinase inhibitors in the treatment of renal cell carcinoma. Crit Rev Oncol Hematol 60 (2006) 216-226
26. Heikaus S., Casliskan E., Mahotka C., Gabbert H.E., and Ramp U. Differential gene expression in anticancer drug- and TRAIL-mediated apoptosis in renal cell carcinomas. Apoptosis 12 (2007) 1645-1657
27. Kelly J.D., Dai J., Eschwege P., et al. Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas. Br J Cancer 91 (2004) 164-170
28. Ramp U., Caliskan E., Mahotka C., et al. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage. Br J Cancer 88 (2003) 1800-1807